The Forums › Forums › Ask The Community › Ampakine CX1739? over the counter nootropics? › Re: Ampakine CX1739? over the counter nootropics?
Update (I think) might be a setback, who knows… Cortex sold their rights for ampakine CX 717 to Biovail, who got swallowed by Valeant. The good news is that CX717 is in the pipeline, but I figure I’ll be dead by the time it gets to market.
http://www.valeant.com/products/pipeline/index.jsp
“Cortex retains all rights to the non-acquired AMPAKINE compounds for treatment of neurodegenerative diseases and psychiatric diseases which historically have been part of its portfolio. “As a result of this transaction, we will be in the position to continue the oral Phase IIa sleep apnea trial with CX1739 and to initiate a Phase II clinical trial for the treatment of ADHD very soon,” commented Mark A Varney. “Additionally, we are pushing ahead to develop the CX2007 and CX2076 series of compounds and move one of those analogs into the clinic as soon as possible.”
REPORT ABUSE